PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-227

  1. 236 Posts.
    lightbulb Created with Sketch. 29
    yippie for what . ?? ..a sea of red at the moment....PAR needs a partner quickly or it will be very difficult to finance the future testing....not happy at all .....
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.